Case Report
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
in Thoracic Oncology
- 395 views
Case Report
Published on 08 Oct 2025
in Thoracic Oncology
Original Research
Published on 08 Oct 2025
in Neurological Biomarkers
Case Report
Published on 08 Oct 2025
in Genitourinary Oncology
Case Report
Published on 08 Oct 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Published on 08 Oct 2025
in Public Health and Nutrition
Case Report
Published on 08 Oct 2025
in Gynecological Oncology
Review
Published on 08 Oct 2025
in Brain Disease Mechanisms
Original Research
Published on 08 Oct 2025
in Neurocognitive Aging and Behavior
Editorial
Published on 08 Oct 2025
in Signaling
Original Research
Published on 08 Oct 2025
in ADHD
Original Research
Published on 08 Oct 2025
in Clinical and Diagnostic Microbiology and Immunology
Original Research
Published on 08 Oct 2025
in Work, Employment and Organizations
Original Research
Published on 08 Oct 2025
in Addictive Disorders
Original Research
Published on 08 Oct 2025
in Cancer Immunity and Immunotherapy
Perspective
Published on 08 Oct 2025
in Intensive Care Medicine and Anesthesiology
Original Research
Published on 08 Oct 2025
in STEM Education